Cerêve is developing a therapeutic device for the treatment of insomnia.
Inari Medical is a medical device company pioneering innovative devices for the interventional treatment of vascular thrombi and emboli.
Metavention is developing novel interventional therapies for type 2 diabetes.
Sebacia is developing a medical device to cure acne.
Zyga is developing and marketing innovative, minimally invasive surgical solutions to treat conditions of the spine.
Rox is developing devices for treatment of diseases of the respiratory system.
Respicardia is developing an implantable system to treat central sleep apnea in patients with heart failure.
OraMetrix is a leading industry provider of innovative 3-D technology solutions facilitating and improving the quality of orthodontic care.
Neurotech Pharmaceuticals is pioneering encapsulated cell technology as a drug delivery platform for retinal degenerative diseases.
Minerva is developing next–generation technology for treating excessive menstrual bleeding.
Microfabrica has developed a broad micro-scale platform for minimally invasive procedures and for complex dynamic implants.
Intuity Medical, formerly Rosedale, is developing a handheld, all in-one discrete, blood-based diagnostic platform that will enhance glucose monitoring for diabetic patients.
Novel devices to treat obstructive lung disease. Previously, Innovative Pulmonary Solutions.
Halscion is advancing a solution for reduction of surgically induced scarring.
ForSight VISION4 is evaluating a variety of technologies to address important unmet patient needs in key ophthalmic markets.
ForSight Vision 5, Inc. is developing novel ocular drug delivery technologies.
Ceterix is developing a new orthopedic suturing technology that is focused on improving ease-of-use and operative speed.
Celula is developing rare cell isolation technology for diagnostic and therapeutic purposes.
Benvenue Medical is developing and marketing innovative spine repair technology.
AlterG is marketing its “G-Trainer” technology, a treadmill system that reduces the users’ body weight/impact of running and thereby enhances physical rehabilitation from orthopedic or neurological injury.
AcuFocus is developing a corneal implant to treat presbyopia (the need for reading glasses).